Topiramate related obsessive-compulsive disorder.
Ozkara
Cigdem
C
Department of Neurology, Istanbul University, Cerrahpasa Medical Faculty, Cerrahpasa Cad, Kocamustafapasa, 34230, Istanbul, Turkey. cigdemoz@istanbul.edu.tr
Ozmen
Mine
M
Erdogan
Ayten
A
Yalug
Irem
I
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004828:Epilepsies, Partial / Q000188:drug therapy; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D000077236:Topiramate; D014227:Triazines / Q000627:therapeutic use
D000927:Anticonvulsants; D018687:Antidepressive Agents, Second-Generation; D014227:Triazines; D015283:Citalopram; D000077236:Topiramate; D005632:Fructose; D002220:Carbamazepine; D000077213:Lamotrigine